These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18779315)

  • 21. A novel NFIA-NFκB feed-forward loop contributes to glioblastoma cell survival.
    Lee J; Hoxha E; Song HR
    Neuro Oncol; 2017 Apr; 19(4):524-534. PubMed ID: 27994064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
    Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
    Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INGs are potential drug targets for cancer.
    Zhang R; Jin J; Shi J; Hou Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):189-197. PubMed ID: 27544390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miz1, a Novel Target of ING4, Can Drive Prostate Luminal Epithelial Cell Differentiation.
    Berger PL; Winn ME; Miranti CK
    Prostate; 2017 Jan; 77(1):49-59. PubMed ID: 27527891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of NF-κB in the pathogenesis of glioma.
    Puliyappadamba VT; Hatanpaa KJ; Chakraborty S; Habib AA
    Mol Cell Oncol; 2014; 1(3):e963478. PubMed ID: 27308348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ubiquitination of NF-κB Subunits in the Control of Transcription.
    Collins PE; Mitxitorena I; Carmody RJ
    Cells; 2016 May; 5(2):. PubMed ID: 27187478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma.
    Zhao D; Liu X; Zhang Y; Ding Z; Dong F; Xu H; Wang B; Wang W
    Oncol Lett; 2016 Apr; 11(4):2869-2874. PubMed ID: 27073567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Koumine Attenuates Lipopolysaccaride-Stimulated Inflammation in RAW264.7 Macrophages, Coincidentally Associated with Inhibition of NF-κB, ERK and p38 Pathways.
    Yuan Z; Matias FB; Wu J; Liang Z; Sun Z
    Int J Mol Sci; 2016 Mar; 17(3):430. PubMed ID: 27011173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor of growth-4 is a potential target for cancer therapy.
    Yuan S; Jin J; Shi J; Hou Y
    Tumour Biol; 2016 Apr; 37(4):4275-9. PubMed ID: 26803518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
    Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
    Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.
    Rajbhandari R; McFarland BC; Patel A; Gerigk M; Gray GK; Fehling SC; Bredel M; Berbari NF; Kim H; Marks MP; Meares GP; Sinha T; Chuang J; Benveniste EN; Nozell SE
    Oncotarget; 2015 Jul; 6(19):17805-16. PubMed ID: 26164206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
    McWilliams IL; Rajbhandari R; Nozell S; Benveniste E; Harrington LE
    J Neuroinflammation; 2015 Jun; 12():128. PubMed ID: 26123499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer.
    Yan R; He L; Li Z; Han X; Liang J; Si W; Chen Z; Li L; Xie G; Li W; Wang P; Lei L; Zhang H; Pei F; Cao D; Sun L; Shang Y
    Genes Dev; 2015 Mar; 29(6):672-85. PubMed ID: 25792601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide expression analysis in fibroblast cell lines from probands with Pallister Killian syndrome.
    Kaur M; Izumi K; Wilkens AB; Chatfield KC; Spinner NB; Conlin LK; Zhang Z; Krantz ID
    PLoS One; 2014; 9(10):e108853. PubMed ID: 25329894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.
    Gray GK; McFarland BC; Nozell SE; Benveniste EN
    Expert Rev Neurother; 2014 Nov; 14(11):1293-306. PubMed ID: 25262780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.
    Gray GK; McFarland BC; Rowse AL; Gibson SA; Benveniste EN
    Oncotarget; 2014 Aug; 5(15):6484-96. PubMed ID: 25153725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
    McFarland BC; Hong SW; Rajbhandari R; Twitty GB; Gray GK; Yu H; Benveniste EN; Nozell SE
    PLoS One; 2013; 8(11):e78728. PubMed ID: 24244348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.
    Ghosh S; Paul A; Sen E
    Mol Cell Biol; 2013 Jul; 33(14):2718-31. PubMed ID: 23671189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.